Research Topics
| James C KingSummaryAffiliation: University of Maryland Country: USA Publications
| Collaborators
|
Detail Information
Publications
A double-blind, placebo-controlled, pilot study of bovine lactoferrin supplementation in bottle-fed infantsJames C King
Department of Pediatrics, School of Medicine, University of Maryland, Baltimore, USA
J Pediatr Gastroenterol Nutr 44:245-51. 2007..The aim of this randomized, placebo-controlled, double-blind study was to examine the impact of bovine lactoferrin supplementation in infants...
Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 monthsJames C King
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Vaccine 27:6589-94. 2009..Recombinant baculovirus-expressed hemagglutinin (rHA [FluBlok]) influenza vaccine is unique in avoiding production in eggs and its rapid production capability...
Effectiveness of school-based influenza vaccinationJames C King
Department of Pediatrics, University of Maryland School of Medicine, 737 W Lombard St, Baltimore, MD 21201, USA
N Engl J Med 355:2523-32. 2006..Vaccination of children in school is one strategy to reduce the spread of influenza in households and communities...
A pilot study of the effectiveness of a school-based influenza vaccination programJames C King
Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, USA
Pediatrics 116:e868-73. 2005..The objective of this study was to evaluate the feasibility of a school-based influenza immunization program...
Safety, vaccine virus shedding and immunogenicity of trivalent, cold-adapted, live attenuated influenza vaccine administered to human immunodeficiency virus-infected and noninfected childrenJ C King
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
Pediatr Infect Dis J 20:1124-31. 2001..To assess the safety of live, attenuated influenza vaccine (LAIV) administered to relatively asymptomatic or mildly symptomatic HIV-infected children and non-HIV-infected children...
Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of MarylandJames C King
University of Maryland School of Medicine, Department of Pediatrics, USA
Vaccine 28:7737-42. 2010..I., 3-9%) in adults aged >50 years for every 20% increase in vaccination rates (p<0.023) for which we have no plausible biologic explanation. No significant changes in deaths were noted...
Direct and indirect impact of influenza vaccination of young children on school absenteeismJames C King
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
Vaccine 30:289-93. 2012..05). These results suggest both direct and indirect benefits of influenza vaccination of young children...
Successful use of volunteers to conduct school-located mass influenza vaccination clinicsGinny E Cummings
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
Pediatrics 129:S88-95. 2012..To determine the feasibility of using volunteers to assist in school-located mass vaccination clinics for influenza...
Benefits and costs of immunizing children against influenza at school: an economic analysis based on a large-cluster controlled clinical trialJordana Schmier
MedImmune Inc in Gaithersburg, Maryland, USA
Health Aff (Millwood) 27:w96-104. 2008..The results show that immunization reduces disease among children and adults and is cost-saving to society. An epidemiologically based influenza immunization policy might be an important supplement to the existing risk-based policy...
Countywide school-based influenza immunization: direct and indirect impact on student absenteeismMollie M Davis
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland 21205, USA
Pediatrics 122:e260-5. 2008..We examined the impact of this community-based intervention on countywide student absenteeism during the subsequent influenza outbreak...
Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adultsJames D Campbell
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland 21201, USA
J Infect Dis 186:1848-51. 2002....
Comparison of the safety, vaccine virus shedding, and immunogenicity of influenza virus vaccine, trivalent, types A and B, live cold-adapted, administered to human immunodeficiency virus (HIV)-infected and non-HIV-infected adultsJ C King
Center for Vaccine Development, University of Maryland School of Medicine, Baltimore, MD 21201, USA
J Infect Dis 181:725-8. 2000..The data suggest that inadvertent vaccination with LAIV in relatively asymptomatic HIV-infected adults would not be associated with frequent significant adverse events...
Group-specific antibody levels surrounding invasive pneumococcal illness in children infected with human immunodeficiency virusJ C King
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD 21201, USA
J Infect Dis 181:1817-21. 2000..Heterologous, noninfecting group seroresponses were detected frequently (72%) in the paired serum samples from these 4 homologous group seroresponders...
Pediatrician attitudes concerning school-located vaccination clinics for seasonal influenzaVirginia A Keane
University of Maryland Department of Pediatrics, 737 W Lombard Street, Baltimore, MD 21201, USA
Pediatrics 129:S96-S100. 2012..We determined the degree to which pediatricians support routine annual influenza vaccination outside the medical home, especially in school-located mass influenza vaccination clinics...
Relationship of influenza vaccine match and use rate to medically attended acute respiratory illnesses in older residents of Maryland. November 13, 2012James C King
Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD, USA
Vaccine 31:839-44. 2013..A/H3N2 viruses were clearly associated with more frequent MAARI-related ED visits and hospitalizations than A/H1N1 and B viruses...
Administration of palivizumab: a medical provider's perspectiveElizabeth A Helm
Department of Pediatrics, Division of General Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland 21201-1512, USA
Clin Pediatr (Phila) 42:821-6. 2003
The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humansPeter F Wright
Division of Pediatric Infectious Disease, Vanderbilt University Medical Center, Nashville, TN 37232, USA
J Infect Dis 193:573-81. 2006..In the present study, the NS2 gene, whose encoded protein antagonizes the host's interferon- alpha / beta response, was deleted from RSV vaccine candidates by use of reverse genetics...
